← Eichor
Condition: Extragonadal Embryonal Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Extragonadal Embryonal Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
Phase 2 · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT06418789Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · 629 location(s) · Children's Oncology Group · NCT03067181
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.